Rare diseases
Investigational molecules
Locations
Ul Marcina Kasprzaka 17 A, 01-211 Warsaw, Poland
Clinical research at Instytut Matki I Dziecka includes treatment-focused studies in refractory primary bone tumors, with attention to Ewing's sarcoma, high-grade osteosarcoma, and relapsed/refractory osteosarcoma. The work is centred on improving disease control in children and adolescents with difficult-to-treat skeletal malignancies.
Research interests also extend to event-free survival and the relationship between clinical outcomes and molecular characteristics of the tumour.
Instytut Matki I Dziecka runs clinical trials in conditions such as Erdheim-Chester disease, Rosai-Dorfman syndrome, Langerhans cell sarcoma, Langerhans' cell histiocytosis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
PolandPolandPolandPolandPolandPolandPolandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
